VOORHEES, N.J., March 1, 2011 /PRNewswire/ -- Hereditary angioedema (HAE) is an autosomal dominant disorder resulting from a deficiency in functional C1 inhibitor. Manifestations include recurrent episodes of nonpitting subcutaneous and submucosal edema involving the skin, airway, and visceral organs. Skin swelling may be the first manifestation of HAE so it is important for dermatologists to understand the cause of and treatments for this condition.
To address the need for current education on HAE, Robert Michael Educational Institute LLC (RMEI) and Postgraduate Institute for Medicine (PIM) are jointly sponsoring this complimentary continuing medical education monograph. This activity is supported by an educational grant from ViroPharma Incorporated.
Marc A. Riedl, MD, MS, Assistant Professor of Medicine at the University of California David Geffen School of Medicine in Los Angeles, California, serves as faculty reviewer for this activity.
Healthcare professionals can visit www.RMEI.com/HAE261MN to participate in this activity.
RMEI is a medical education company that specializes in independent continuing medical education designed for clinicians to improve and deliver quality medical care to patients. The goal of RMEI educational offerings is to promote continuous professional development and the improvement of health outcomes. RMEI works closely with medical experts to develop activities that improve diagnosis and treatment leading to better outcomes for patients. These activities include national and international symposia, teleconferences, live meetings, enduring print materials, and interactive Internet programs.
For other educational opportunities, please visit www.RMEI.com.